2022
DOI: 10.1007/s40005-022-00602-x
|View full text |Cite
|
Sign up to set email alerts
|

Formulation development and pharmacokinetic evaluation of enteric-coated dexrabeprazole tablets

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 24 publications
0
2
0
Order By: Relevance
“…The in vitro dissolution pattern of SOL from the DCTs was evaluated using the USP Paddle 2 method (VK750D, Varian, Huntington Beach, CA, USA) [ 23 ]. Simulated gastric fluid (pH 1.2), sodium acetate buffer (pH 4.0), simulated intestinal fluid (pH 6.8), and distilled water were used as the dissolution media.…”
Section: Methodsmentioning
confidence: 99%
“…The in vitro dissolution pattern of SOL from the DCTs was evaluated using the USP Paddle 2 method (VK750D, Varian, Huntington Beach, CA, USA) [ 23 ]. Simulated gastric fluid (pH 1.2), sodium acetate buffer (pH 4.0), simulated intestinal fluid (pH 6.8), and distilled water were used as the dissolution media.…”
Section: Methodsmentioning
confidence: 99%
“…The average plasma pharmacokinetic parameters, including the area under the curve from time 0 extrapolated to infinity (AUC inf ) and the terminal half-life (t 1/2 ), were determined using a non-compartment model (WinNonlin Ver. 3.1; Certara, Inc., Princeton, NJ, USA) [ 43 ]. The peak time (T max ) and maximal concentration (C max ) were obtained directly from the observed plasma concentration-time profiles.…”
Section: Methodsmentioning
confidence: 99%